Kallmann syndrome

Kallmann syndrome is an example of hypogonadism(decreased functioning of the sex hormone-producing glands) caused by a deficiency of gonadotropin-releasing hormone(GnRH), which is created by the hypothalamus. Kallmann syndrome is also known as hypothalamichypogonadism, familial hypogonadism with anosmia, or gonadotropichypogonadism, reflecting its disease mechanism.

Kallman syndrome was described in 1944by Franz Josef Kallmann, a Germangeneticist. However, others had noticed a correlation between anosmia and hypogonadism before this such as the Spanish doctor Aureliano Maestre de San Juan80 years previously.

Features

Kallmann syndrome is characterized by:

• Hypogonadotropic hypogonadism(a lack of the pituitary hormonesLHand FSH)
• Congenital (present from birth) anosmia(complete inability to smell) or hyposmia (decreased ability to smell).

It can also be associated with optic problems, such as color blindness or optic atrophy, nerve deafness, cleft palate, cryptorchidism, renal agenesis, and mirror movement disorder. However, it is not clear at this time how or if these other problems have the same cause as the hypogonadism and anosmia and these other problems are more often present in those without Kallmann syndrome. Image:Kallmann1.jpg Males present with delayed puberty and may have micropenis(although congenital micropenis is not present in the majority of male KS cases).

Females present with delayed puberty i.e.primary amenorrheaand lack of secondary sex characteristicd, such as breast development.

Diagnosis

The diagnosis is often one of exclusion found during the workup of delayed puberty. The presence of anosmia together with micropenis in boys should suggest Kallmann syndrome (although micropenis alone may have other causes).

Pathophysiology

Under normal conditions, GnRH travels to the pituitary glandvia the tuberoinfundibular pathway, where it triggers production of gonadotropins(LHand FSH). When GnRH is low, the pituitary does not create the normal amount of gonadotropins. The gonadotropins in turn affect the production of hormonesin the gonads, so when they are low, these hormones will be low as well.

In Kallmann syndrome, the GnRH neurons do not migrate properly from the olfactory placode to the hypothalamus during development. The olfactory bulbs also fail to form or have hypoplasia, leading to anosmia or hyposmia.

Kallman syndrome can be inherited as an X-linked recessive trait, in which case there is a defect in the KALgene, which maps to chromosome Xp22.3. KAL encodes a neural cell adhesion molecule, anosmin-1. Anosmin-1 is normally expressed in the brain, facialmesenchyme, mesonephros and metanephros. It is required to promote migration of GnRH neurons from the hypothalamus to the pituitary gland. It also allows migration of olfactory neurons from the olfactory bulbsto the hypothalamus.

Treatment

Treatment is directed at restoring the deficient hormones -- known as hormone replacement therapy(HRT). Males are administered human chorionic gonadotropin(hCG) or testosterone. Females are treated with oestrogenand progestins.

To induce fertility in males or females, GnRH (aka LHRH) is administered by an infusion pump, or hCG/hMG/FSH/LH combinations are administered through regular injections. Fertility is only maintained whilst actually being treated with these hormones. Once fertility treatment stops it is necessary to revert to the normal HRT of testosterone for men and oestrogen + progestins for women.

The main health risk, for both men and women, of untreated Kallmann Syndrome is osteoporosis. Therefore, regular bone density scans (every 2 years or so) are advisable, even if being treated with HRT. Additional medication specifically for osteoporosis is necessary in some cases.

Epidemiology

Kallmann syndrome occurs at a rate of 1 in 10,000 male births and 1 in 50,000 female births. It may be inherited as an X-linked condition, an autosomal dominant condition or as an autosomal recessive condition. Statistics are sparse, but it seems that autosomal dominant is the most common form of heredity.

Even though mutations in the KAL gene on the X chromosome can cause Kallmann syndrome, only 11-14% of patients with Kallmann syndrome have detectable KAL mutations. Mutations in autosomal gene FGFR1 have been found in some cases. As yet no recessive gene has been identified.

There may also be no obvious family history of inheritance (sporadic cases). However, it is possible for Kallmann's gene(s) to be passed on to children of a sporadic case.

Resources

• Kallmann FJ, Schönfeld WA, Barrera SE. The genetic aspects of primary eunuchoidism. Am J Ment Defic 1943-1944;48:203-236.
• OMIM308700(Kallmann syndrome 1), OMIM147950(Kallmann syndrome 2)
• Kallmann's Syndrome Mailing List

External links

• Man, 33, seeks puberty(BBC)de:Olfaktogenitales Syndrom

fr:Syndrome de Kallmann nl:Syndroom van Kallmann

This article is licensed under the GNU Free Documentation License.
It uses material from the http://en.wikipedia.org/wiki/Kallmann+syndrome Wikipedia article Kallmann syndrome.